Structures of oxaliplatin‐oligonucleotide adducts from DNA
- 27 September 2012
- journal article
- research article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 47 (10) , 1282-1293
Abstract
Oxaliplatin, [(1R,2R)‐cyclohexane‐1,2‐diamine](ethanedioato‐O,O')platinum(II) shows a great efficiency against colorectal cancer. Although the mode of action of oxaliplatin is not yet understood, it is commonly accepted that binding of oxaliplatin to DNA prevents DNA synthesis and alters protein to DNA binding. In order to elucidate the modified DNA–protein interaction and thus to understand the mechanisms leading to cellular misinterpretation of DNA information and apoptosis, we have identified the preferential binding sites and the dynamics of the oxaliplatin‐DNA intrastrand and interstrand adducts at the oligomer level using high‐performance liquid chromatography/electrospray ionization‐tandem mass spectrometry (HPLC/ESI‐MS/MS) and HPLC/inductively coupled plasma‐MS for quantitative studies. We used a combination of benzonase, alkaline phosphatase and Nuclease S1 for digestion. This digestion procedure allows the study of platinated oligomeric nucleotides and more complex interstrand adducts. The digestion products were mostly chromatographically separated and characterized using HPLC/ESI‐ion trap MS/MS experiments. We could show that the adducts to guanine and adenine are quite dynamic; that is, the ratios are changing for several days. In addition, the resulting adducts provide evidence for the action of the digesting enzymes and indicate that the adduct spectrum at the oligomeric level is different to that at the commonly studies dinucleotide level. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 29 references indexed in Scilit:
- Quantitative Profiling of in Vivo Generated Cisplatin−DNA Adducts Using Different Isotope Dilution StrategiesAnalytical Chemistry, 2009
- Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews, 2007
- Detection of oxaliplatin-induced DNA crosslinks in vitro and in cancer patients using the alkaline comet assayDNA Repair, 2006
- Comparative analysis of the mutagenic activity of oxaliplatin and cisplatin in the Hprt gene of CHO cellsEnvironmental and Molecular Mutagenesis, 2005
- Mass spectrometry of cis‐diamminedichloroplatinum(II) adducts with the dinucleosidemonophosphates d(ApG), d(GpG) and d(TpC) in an ion trapJournal of Mass Spectrometry, 2002
- Reactivity and Inertness of Pt‐Nucleobase Complexes1999
- Steric Parameters for Metal Binding Sites on NucleobasesInorganic Chemistry, 1996
- Low-energy collision-induced dissociation of deprotonated dinucleotides: determination of the energetically favored dissociation pathways and the relative acidities of the nucleic acid basesInternational Journal of Mass Spectrometry and Ion Processes, 1994
- Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethalityBiochemistry, 1990
- Characterization of adducts produced in DNA by isomeric 1,2-diaminocyclohexaneplatinum(II) complexesChemico-Biological Interactions, 1989